光学前臨床イメージング市場：製品タイプ別、最終用途別-2025～2030年の世界予測

光学前臨床イメージング市場は、2023年に13億2,000万米ドルと評価され、2024年には15億1,000万米ドルに達すると予測され、CAGR 14.39％で成長し、2030年には33億9,000万米ドルになると予測されています。

光学前臨床イメージング市場は、主にげっ歯類を中心とした生きた動物の病気の進行、薬剤の有効性、生物学的プロセスをモニターするための実験室研究段階で使用される非侵襲的可視化技術に焦点を当てています。このニッチ市場はトランスレーショナルリサーチに必要であり、動物モデルから洞察はヒトの病気の理解と治療に貢献し、医薬品開発と生物医療に不可欠です。用途は腫瘍学、神経学、心臓病学、幹細胞研究など多岐にわたり、その使用は学術機関、製薬、バイオテクノロジーセグメントの前臨床に不可欠です。主要成長促進要因としては、解像度と感度を高める蛍光や生物発光などのイメージング技術の技術進歩が挙げられます。慢性疾患の増加、研究開発費の増加、人体実験や動物実験に代わるより倫理的な代替法の推進は、市場拡大のさらなる原動力となっています。画像分析を強化するための人工知能の統合、小型化、生体システム全体にわたる包括的な洞察を提供するマルチモーダル画像システムの開発などに新たなビジネス機会があります。しかし市場は、高額な機器コスト、複雑な規制状況、熟練した人材の需要といった制約に直面しており、新規参入の障壁となっています。進化する倫理基準の遵守と、ヒトの疾患を正確に模倣する動物モデルの検証は、依然として課題です。将来の技術革新は、イメージング技術の侵襲性とコストを低減し、その利用可能性を広げることに焦点を当てることができると考えられます。企業は、最先端の進歩を活用するために学術研究機関との提携に投資し、研究インフラが成長している新興地域での市場を追求することが推奨されます。光学前臨床イメージング市場の性質はダイナミックであり、急速な技術革新と様々なライフサイエンスセグメントとの強い結びつきが原動力となっています。

市場力学：急速に進化する光学前臨床イメージング市場の主要市場洞察を公開

光学前臨床イメージング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • さまざまなセグメントでの前臨床イメージング利用の増加
  • 臨床研究機関（CRO）と製薬会社の増加
  • ライフサイエンスと化粧品セグメントでの用途の増加
• 市場抑制要因
  • 高い設置コストと運用コスト
• 市場機会
  • 分子イメージング技術の進歩
  • 前臨床研究を支援するための官民パートナーシップによる資金調達の増加
• 市場課題
  • 厳しい規制の枠組み

ポーターのファイブフォース：光学前臨床イメージング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：光学前臨床イメージング市場における外部からの影響の把握

外部マクロ環境要因は、光学前臨床イメージング市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：光学前臨床イメージング市場における競合情勢の把握

光学前臨床イメージング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：光学前臨床イメージング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、光学前臨床イメージング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：光学前臨床イメージング市場における成功への道筋を描く

光学前臨床イメージング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまなセグメントで前臨床イメージングの利用が増加
    • 臨床研究機関（CRO）と製薬会社の増加
    • ライフサイエンスと化粧品セグメントでの応用が増加
  • 抑制要因
    • 設置コストと運用コストが高い
  • 機会
    • 分子イメージングの技術進歩
    • 臨床前研究を支援する官民パートナーシップからの資金増加
  • 課題
    • 厳格な規制枠組み
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 光学前臨床イメージング市場：製品タイプ別

• イントロダクション
• 消耗品
• デバイス
  • 生物発光
    • セレンテラジン
    • ルシフェリン
    • プロルシフェリン
  • 蛍光
    • 緑色蛍光タンパク質
    • 赤外線染料
    • 赤色蛍光タンパク質
• ソフトウェア

第7章 光学前臨床イメージング市場：最終用途別

• イントロダクション
• 製薬・バイオテクノロジー企業
• 研究機関

第8章 南北アメリカの光学前臨床イメージング市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の光学前臨床イメージング市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの光学前臨床イメージング市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies Inc.
• Analytik Jena GmbH
• Angstrom Advanced Inc
• Aspect Imaging Ltd.
• Berthold Technologies GmbH & Co.KG
• Bruker Corporation
• FUJIFILM Holdings Corporation
• General Electric Company
• INDEC Systems, Inc.
• LI-COR, Inc.
• Magnetic Insight, Inc.
• MBF Bioscience
• Mediso Ltd.
• Milabs B.V.
• Miltenyi BIoTec B.V. & Co. KG

LIST OF FIGURES

• FIGURE 1. OPTICAL PRECLINICAL IMAGING MARKET RESEARCH PROCESS
• FIGURE 2. OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPTICAL PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPTICAL PRECLINICAL IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COELENTERAZINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY LUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PROLUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY GREEN FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY INFRARED DYES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RED FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 159. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 179. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 184. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 234. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Optical Preclinical Imaging Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 14.39%, to USD 3.39 billion by 2030.

The optical preclinical imaging market is focused on non-invasive visualization techniques used in laboratory research stages to monitor disease progression, drug efficacy, and biological processes in live animals, primarily rodents. This niche market is necessary for translational research, where insights from animal models contribute to the understanding and treatment of human diseases, making it indispensable in drug development and biomedicine. Applications extend across oncology, neurology, cardiology, and stem cell research, with its usage vital in academia, pharmaceutical, and biotechnology sectors for preclinical scopes. Key growth drivers include technological advancements in imaging techniques, such as fluorescence and bioluminescence, which enhance resolution and sensitivity. The increasing prevalence of chronic diseases, escalating R&D expenditures, and the push for more ethical alternatives to human and animal testing further fuel market expansion. Emerging opportunities lie in integrating artificial intelligence for enhanced image analysis, miniaturization, and the development of multimodal imaging systems that provide comprehensive insights across biological systems. However, the market faces limitations in high equipment costs, complex regulatory landscapes, and the demand for skilled personnel, which can act as barriers for new entrants. Compliance with evolving ethical standards and the validation of animal models to accurately mimic human diseases remain challenging. Future innovation could focus on reducing the invasiveness and cost of imaging technologies, broadening their accessibility. Companies are recommended to invest in partnerships with academic and research institutions to leverage cutting-edge advancements and to pursue markets in emerging regions where research infrastructure is growing. The nature of the optical preclinical imaging market is dynamic, driven by rapid technological innovation and a strong intersection with various life sciences disciplines, offering vast potential for growth but demanding agility and forward-thinking strategies from stakeholders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased use of preclinical imaging in different sectors
  • Growing number of clinical research organizations (CROs) and pharmaceutical companies
  • Increasing applications in life science and cosmetic
• Market Restraints
  • High installation and operational costs
• Market Opportunities
  • Technological advancement in molecular imaging
  • Rising funding from public-private partnership to support pre clinical researches
• Market Challenges
  • Strict regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Optical Preclinical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optical Preclinical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optical Preclinical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optical Preclinical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optical Preclinical Imaging Market

A detailed market share analysis in the Optical Preclinical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optical Preclinical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optical Preclinical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optical Preclinical Imaging Market

A strategic analysis of the Optical Preclinical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Analytik Jena GmbH, Angstrom Advanced Inc, Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG, Bruker Corporation, FUJIFILM Holdings Corporation, General Electric Company, INDEC Systems, Inc., LI-COR, Inc., Magnetic Insight, Inc., MBF Bioscience, Mediso Ltd., Milabs B.V., and Miltenyi Biotec B.V. & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Optical Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Consumables, Device, and Software. The Device is further studied across Bioluminescence and Fluorescence. The Bioluminescence is further studied across Coelenterazine, Luciferins, and Proluciferins. The Fluorescence is further studied across Green Fluorescent Proteins, Infrared Dyes, and Red Fluorescent Proteins.
• Based on End-Use, market is studied across Pharma & Biotech Companies and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased use of preclinical imaging in different sectors
    • 5.1.1.2. Growing number of clinical research organizations (CROs) and pharmaceutical companies
    • 5.1.1.3. Increasing applications in life science and cosmetic
  • 5.1.2. Restraints
    • 5.1.2.1. High installation and operational costs
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in molecular imaging
    • 5.1.3.2. Rising funding from public-private partnership to support pre clinical researches
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory framework
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Optical Preclinical Imaging Market, by Product Type

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Device
  • 6.3.1. Bioluminescence
    • 6.3.1.1. Coelenterazine
    • 6.3.1.2. Luciferins
    • 6.3.1.3. Proluciferins
  • 6.3.2. Fluorescence
    • 6.3.2.1. Green Fluorescent Proteins
    • 6.3.2.2. Infrared Dyes
    • 6.3.2.3. Red Fluorescent Proteins
• 6.4. Software

7. Optical Preclinical Imaging Market, by End-Use

• 7.1. Introduction
• 7.2. Pharma & Biotech Companies
• 7.3. Research Institutes

8. Americas Optical Preclinical Imaging Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Optical Preclinical Imaging Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Optical Preclinical Imaging Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies Inc.
• 2. Analytik Jena GmbH
• 3. Angstrom Advanced Inc
• 4. Aspect Imaging Ltd.
• 5. Berthold Technologies GmbH & Co.KG
• 6. Bruker Corporation
• 7. FUJIFILM Holdings Corporation
• 8. General Electric Company
• 9. INDEC Systems, Inc.
• 10. LI-COR, Inc.
• 11. Magnetic Insight, Inc.
• 12. MBF Bioscience
• 13. Mediso Ltd.
• 14. Milabs B.V.
• 15. Miltenyi Biotec B.V. & Co. KG